Mihaela Angelova
Mihaela Angelova
The Francis Crick Insitute
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade
P Charoentong, F Finotello, M Angelova, C Mayer, M Efremova, D Rieder, ...
Cell reports 18 (1), 248-262, 2017
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ...
The Lancet 391 (10135), 2128-2139, 2018
Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability
B Mlecnik, G Bindea, HK Angell, P Maby, M Angelova, D Tougeron, ...
Immunity 44 (3), 698-711, 2016
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
M Angelova, P Charoentong, H Hackl, ML Fischer, R Snajder, ...
Genome biology 16, 1-17, 2015
The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
B Mlecnik, G Bindea, A Kirilovsky, HK Angell, AC Obenauf, M Tosolini, ...
Science translational medicine 8 (327), 327ra26-327ra26, 2016
Evolution of metastases in space and time under immune selection
M Angelova, B Mlecnik, A Vasaturo, G Bindea, T Fredriksen, L Lafontaine, ...
Cell 175 (3), 751-765. e16, 2018
Immune evasion before tumour invasion in early lung squamous carcinogenesis
C Mascaux, M Angelova, A Vasaturo, J Beane, K Hijazi, G Anthoine, ...
Nature 571 (7766), 570-575, 2019
The link between the multiverse of immune microenvironments in metastases and the survival of colorectal cancer patients
M Van den Eynde, B Mlecnik, G Bindea, T Fredriksen, SE Church, ...
Cancer cell 34 (6), 1012-1026. e3, 2018
The coordinated action of the MVB pathway and autophagy ensures cell survival during starvation
M Müller, O Schmidt, M Angelova, K Faserl, S Weys, L Kremser, ...
Elife 4, e07736, 2015
miR-22 and miR-29a are members of the androgen receptor cistrome modulating LAMC1 and Mcl-1 in prostate cancer
L Pasqualini, H Bu, M Puhr, N Narisu, J Rainer, B Schlick, G Schäfer, ...
Molecular endocrinology 29 (7), 1037-1054, 2015
Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution
S Venkatesan, M Angelova, C Puttick, H Zhai, DR Caswell, WT Lu, ...
Cancer discovery 11 (10), 2456-2473, 2021
Endosome and Golgi‐associated degradation (EGAD) of membrane proteins regulates sphingolipid metabolism
O Schmidt, Y Weyer, V Baumann, MA Widerin, S Eising, M Angelova, ...
The EMBO Journal 38 (15), e101433, 2019
The evolution of lung cancer and impact of subclonal selection in TRACERx
AM Frankell, M Dietzen, M Al Bakir, EL Lim, T Karasaki, S Ward, ...
Nature, 1-9, 2023
Bioinformatics for cancer immunology and immunotherapy
P Charoentong, M Angelova, M Efremova, R Gallasch, H Hackl, J Galon, ...
Cancer Immunology, Immunotherapy 61, 1885-1903, 2012
Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18: 248–262
P Charoentong, F Finotello, M Angelova, C Mayer, M Efremova, D Rieder, ...
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
Y Wu, D Biswas, I Usaite, M Angelova, S Boeing, T Karasaki, S Veeriah, ...
Nature cancer 3 (6), 696-709, 2022
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry
F Van Maldegem, K Valand, M Cole, H Patel, M Angelova, S Rana, ...
Nature Communications 12 (1), 5906, 2021
Computational methods for gene finding in prokaryotes
M Angelova, S Kalajdziski, L Kocarev
ICT Innovations 2010 Web Proceedings, 2010
The colorectal cancer immune paradox revisited
M Angelova, P Charoentong, H Hackl, Z Trajanoski
Oncoimmunology 5 (2), e1078058, 2016
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
FC Martins, DL Couturier, I De Santiago, CM Sauer, M Vias, M Angelova, ...
Nature Communications 13 (1), 6360, 2022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20